Caroline H.
- Country
- France
- Department
- Neuro-onclologie
Research Overview
- Evaluation of Emavusertib and Ibrutinib in Relapsed/Refractory Primary Central Nervous System Lymphoma: A Dose Escalation and Expansion Study
- Evaluation of [18F]-Fludarabine and Gadoteric Acid PET/MR Imaging in Newly Diagnosed Primary CNS Lymphoma Patients Prior to Therapeutic Intervention
- Phase 2 Evaluation of Epcoritamab with Lenalidomide and Rituximab in Relapsed/Refractory Primary CNS Diffuse Large B-Cell Lymphoma
Data & Insights
Has run more than one trial at 7 of 46 partner sites.
Specializations
CNS Lymphoma Treatment
The investigator specializes in treating primary central nervous system lymphoma (PCNSL), with particular focus on both newly diagnosed and relapsed/refractory cases.
- Novel therapeutic combinations
- Targeted induction treatments
- Innovative drug protocols
Expertise extends to managing complex cases of diffuse large B-cell lymphoma of the CNS.
Diagnostic Innovation
Pioneering work in advanced imaging techniques for CNS lymphoma diagnosis, including PET/MR imaging methodologies and novel radiotracer applications.
- Pre-treatment assessment protocols
- Diagnostic imaging techniques
- Brain tumor visualization
Specialized in evaluating cerebral distribution patterns in lymphoma patients.
Treatment Development
Active involvement in developing targeted therapeutic approaches for CNS lymphoma, incorporating both established and experimental treatments.
- Drug combination strategies
- Dose optimization protocols
- Response assessment methods
Focus on improving outcomes for patients with resistant or recurring disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.